Retrophin Inc (RTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RTRX | PHAT | PVLA | ||
| Company | Retrophin Inc | Phathom Pharmaceuticals Inc | Palvella Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.57 | 17.90 | 99.73 | ||
| High | 24.74 | 18.28 | 114.69 | ||
| Low | 24.04 | 17.29 | 99.02 | ||
| Latest | 24.25 | 17.87 | 109.07 | ||
| Change | -0.11 | +0.34 | +9.34 | ||
| % Change | -0.45% | +1.94% | +9.37% | ||
| Volume | 378,900 | 1,259,100 | 269,800 | ||
| 20-Day Average Volume | 335,225 | 1,003,385 | 321,980 | ||
| Previous Close | 24.36 | 17.53 | 99.73 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 22.07 | 15.20 | 97.18 | ||
| 20-Day Raw Stochastic | 86.95% | 90.14% | 81.54% | ||
| 20-Day Relative Strength | 67.64 | 73.07 | 63.48 | ||
| Weighted Alpha | +75.80 | +67.84 | +697.64 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.04% since 11/11/20 | +21.65% since 12/15/25 | +22.58% since 12/15/25 | ||
| Low | 23.33 on 11/13/20 | 14.53 on 12/16/25 | 89.24 on 12/16/25 | ||
| High | 24.74 on 11/18/20 | 18.28 on 12/22/25 | 114.69 on 12/22/25 | ||
| 1-Month | |||||
| %Chg | +10.78% since 10/16/20 | +19.13% since 11/21/25 | +15.92% since 11/21/25 | ||
| Low | 19.52 on 11/02/20 | 14.12 on 12/10/25 | 84.25 on 12/15/25 | ||
| High | 24.96 on 11/11/20 | 18.28 on 12/22/25 | 114.69 on 12/22/25 | ||
| 3-Month | |||||
| %Chg | +31.58% since 08/18/20 | +52.21% since 09/22/25 | +85.78% since 09/22/25 | ||
| Low | 17.22 on 09/24/20 | 10.33 on 10/07/25 | 56.54 on 09/24/25 | ||
| High | 24.96 on 11/11/20 | 18.28 on 12/22/25 | 114.69 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +47.33% since 05/18/20 | +71.50% since 06/20/25 | +394.65% since 06/20/25 | ||
| Low | 14.50 on 06/11/20 | 7.61 on 07/22/25 | 20.35 on 06/27/25 | ||
| High | 24.96 on 11/11/20 | 18.28 on 12/22/25 | 114.69 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,238,011 | 1,247,049 | 1,180,404 | ||
| Shares Outstanding, K | 51,052 | 71,138 | 11,836 | ||
| Annual Sales | 175,340,000 | 55,250,000 | 0 | ||
| Annual Net Income | -146,430,000 | -334,330,000 | -17,430,000 | ||
| Last Quarter Sales | 51,140,000 | 49,500,000 | 0 | ||
| Last Quarter Net Income | -22,550,000 | -29,970,000 | -11,350,000 | ||
| 60-Month Beta | 0.71 | 0.43 | -0.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/24/20 | -0.15 on 10/30/25 | -1.03 on 11/11/25 | ||
| Latest Earnings Date | 02/22/21 | 03/05/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||